Accéder au contenu
Merck

Missense mutations have unexpected consequences: The McArdle disease paradigm.

Human mutation (2018-07-17)
Inés García-Consuegra, Sara Asensio-Peña, Alfonsina Ballester-Lopez, Rosario Francisco-Velilla, Tomás Pinos, Guillem Pintos-Morell, Jaume Coll-Cantí, Adrián González-Quintana, Antoni L Andreu, Joaquín Arenas, Alejandro Lucia, Gisela Nogales-Gadea, Miguel A Martín
RÉSUMÉ

McArdle disease is a disorder of muscle glycogen metabolism caused by mutations in the PYGM gene, encoding for the muscle-specific isoform of glycogen phosphorylase (M-GP). The activity of this enzyme is completely lost in patients' muscle biopsies, when measured with a standard biochemical test which, does not allow to determine M-GP protein levels. We aimed to determine M-GP protein levels in the muscle of McArdle patients, by studying biopsies of 40 patients harboring a broad spectrum of PYGM mutations and 22 controls. Lack of M-GP protein was found in muscle in the vast majority (95%) of patients, irrespective of the PYGM genotype, including those carrying missense mutations, with few exceptions. M-GP protein biosynthesis is not being produced by PYGM mutations inducing premature termination codons (PTC), neither by most PYGM missense mutations. These findings explain the lack of PYGM genotype-phenotype correlation and have important implications for the design of molecular-based therapeutic approaches.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anticorps anti-α-tubuline monoclonal antibody produced in mouse, clone B-5-1-2, purified from hybridoma cell culture
Sigma-Aldrich
Anti-PYGM antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution